Literature DB >> 31405868

Pharmacokinetics and Penetration of Sitafloxacin into Alveolar Epithelial Lining Fluid in Critically Ill Thai Patients with Pneumonia.

Taniya Paiboonvong1, Wichit Nosoongnoen1, Korbtham Sathirakul1, Viratch Tangsujaritvijit2, Jaipak Kaemapairoj2, Pramote Tragulpiankit1, Preecha Montakantikul3.   

Abstract

Sitafloxacin showed potent activity against various respiratory pathogens. Blood and bronchoalveolar lavage (BAL) fluid samples were obtained from 12 subjects after a single oral dose of sitafloxacin 200 mg. The mean ± SD (median) maximum ratio of epithelial lining fluid (ELF) to unbound plasma concentration was 1.02 ± 0.58 (1.33). The penetration ratios based on the mean and median area under the curve from 0 to 8 h (AUC0-8) were 0.85 and 0.79 μg · h/ml, respectively. Sitafloxacin penetrates well into ELF in critically ill Thai patients with pneumonia. (This study has been registered in the Thai Clinical Trials Registry [TCTR] under registration no. TCTR20170222001.).
Copyright © 2019 American Society for Microbiology.

Entities:  

Keywords:  critically ill patients; epithelial lining fluid; pharmacokinetics; sitafloxacin

Mesh:

Substances:

Year:  2019        PMID: 31405868      PMCID: PMC6761513          DOI: 10.1128/AAC.00800-19

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  14 in total

1.  In vitro activity of sitafloxacin against carbapenem-resistant Acinetobacter baumannii.

Authors:  Visanu Thamlikitkul; Surapee Tiengrim
Journal:  Int J Antimicrob Agents       Date:  2013-07-19       Impact factor: 5.283

2.  Pharmacokinetics and tolerance of DU-6859a, a new fluoroquinolone, after single and multiple oral doses in healthy volunteers.

Authors:  M Nakashima; T Uematsu; K Kosuge; K Umemura; H Hakusui; M Tanaka
Journal:  Antimicrob Agents Chemother       Date:  1995-01       Impact factor: 5.191

Review 3.  Penetration of anti-infective agents into pulmonary epithelial lining fluid: focus on antibacterial agents.

Authors:  Keith A Rodvold; Jomy M George; Liz Yoo
Journal:  Clin Pharmacokinet       Date:  2011-10       Impact factor: 6.447

Review 4.  Considerations for effect site pharmacokinetics to estimate drug exposure: concentrations of antibiotics in the lung.

Authors:  Keith A Rodvold; William W Hope; Sara E Boyd
Journal:  Curr Opin Pharmacol       Date:  2017-10-31       Impact factor: 5.547

5.  In vitro Activity of Sitafloxacin and Other Antibiotics against Bacterial Isolates from HRH Princess Maha Chakri Sirindhorn Medical Center, Srinakharinwirot University and Samitivej Sukhumvit Hospital.

Authors:  Woraphot Tantisiriwat; Patcharasarn Linasmita
Journal:  J Med Assoc Thai       Date:  2017-04

Review 6.  Sitafloxacin: in bacterial infections.

Authors:  Gillian M Keating
Journal:  Drugs       Date:  2011-04-16       Impact factor: 9.546

7.  Pharmacokinetics and intrapulmonary diffusion of levofloxacin in critically ill patients with severe community-acquired pneumonia.

Authors:  Emmanuel Boselli; Dominique Breilh; Thomas Rimmelé; Sarah Djabarouti; Marie-Claude Saux; Dominique Chassard; Bernard Allaouchiche
Journal:  Crit Care Med       Date:  2005-01       Impact factor: 7.598

8.  Pharmacodynamics of intravenous ciprofloxacin in seriously ill patients.

Authors:  A Forrest; D E Nix; C H Ballow; T F Goss; M C Birmingham; J J Schentag
Journal:  Antimicrob Agents Chemother       Date:  1993-05       Impact factor: 5.191

9.  Comparative in vitro activity of sitafloxacin against bacteria isolated from Thai patients with urinary tract infections and lower respiratory tract infections.

Authors:  Surapee Tiengrim; Danabhand Phiboonbanakit; Sudaluck Thunyaharn; Woraphot Tantisiriwat; Somchai Santiwatanakul; Wattanachai Susaengrat; Nuttiya Srisurat; Amnat Malithong; Praphatsorn Srisangchan; Visanu Thamlikitkul
Journal:  J Med Assoc Thai       Date:  2012-02

10.  Permeability and concentration of levofloxacin in epithelial lining fluid in patients with lower respiratory tract infections.

Authors:  Jing Zhang; Xin Xie; Xin Zhou; Yu-Qing Chen; Ji-Cheng Yu; Guo-Ying Cao; Xiao-Jie Wu; Yao-Guo Shi; Ying-Yuan Zhang
Journal:  J Clin Pharmacol       Date:  2009-12-24       Impact factor: 3.126

View more
  1 in total

Review 1.  Penetration of Antibacterial Agents into Pulmonary Epithelial Lining Fluid: An Update.

Authors:  Emily N Drwiega; Keith A Rodvold
Journal:  Clin Pharmacokinet       Date:  2021-10-15       Impact factor: 6.447

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.